Stock Events

Stock Events

Acrivon Therapeutics (ACRV) Q4 2025 Earnings

13NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.66

-0.6

-0.53

-0.47

Details

Expected EPS

-0.591111

Actual EPS

-0.47

Surprise EPS

0.12

Surprise Percent

+20.49%

Description

Acrivon Therapeutics (ACRV) has reported earnings of -0.47 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.